vimarsana.com

Latest Breaking News On - Orbit discovery - Page 1 : vimarsana.com

Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics

Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

Secarna pharmaceuticalsmayKonstantin petropoulosSecarna pharmaceuticals gmbh coOrbit discovery ltdFrom secarna pharmaceuticalsmayOrbit discovery

Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-conjugated Targeted Antisense Oligonucleotide Therapeutics

Partnership expands spectrum of Secarna's capabilities for the development of targeted ASOs beyond antibodies and sugar molecules New platform capabilities extend the reach of Secarna's antisense

Lily jefferyKonstantin petropoulosOrbit discovery ltdZyme communicationsSecarna pharmaceuticals weSecarna pharmaceuticals gmbh coOrbit discoverySecarna pharmaceuticalsNeil buttChief executive officerIhr portfolio

Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics

MARTINSRIED, GERMANY and OXFORD, UK - EQS Newswire - 28 May 2024 - Secarna Pharmaceuticals GmbH & Co. KG (Secarna), a leading independent European

United kingdomKonstantin petropoulosSecarna pharmaceuticals gmbh coSecarna pharmaceuticalsProfessor graham ogg university of oxfordOrbit discovery ltdSecarna pharmaceuticals weSecarna pharmaceuticals gmbhOrbit discoveryNeil buttChief executive officerDiscovery ltdOxford science parkProfessor graham oggProfessor terry rabbitsCancer research

Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conj

EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): AgreementSecarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics 28.05.2024 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announ.

United kingdomAlexander gebauerLily jefferyAnne hennecke vera langKonstantin petropoulosMc servicesZyme communicationsOrbit discovery ltdSecarna pharmaceuticals gmbh coDistribution servicesSecarna pharmaceuticals weProfessor graham ogg university of oxfordMedia enquiries for secarna pharmaceuticalsSecarna pharmaceuticalsSecarna pharmaceuticals gmbhOrbit discovery

Orano Med and Orbit partner for radionuclide therapies discovery

Orano Med and Orbit Discovery have entered into a partnership for the discovery of specific peptide receptor radionuclide therapies against cancer cells.

Julien dodetNeil buttOrano medTargeted alpha therapyOrbit discovery

vimarsana © 2020. All Rights Reserved.